[HTML][HTML] SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach

H Yousefi, A Poursheikhani, Z Bahmanpour… - Biomedicine & …, 2020 - Elsevier
Although 70% of the genome is transcribed to RNA in humans, only∼ 2% of these
transcripts are translated into proteins. The rest of the transcripts are defined as noncoding …

Interactions among regulatory non-coding RNAs involved in cardiovascular diseases

AF Gabriel, MC Costa, FJ Enguita - Non-coding RNAs in Cardiovascular …, 2020 - Springer
Non-coding RNAs (ncRNAs) are important regulatory players in human cells that have been
shown to modulate different cellular processes and biological functions through controlling …

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

A Dwivedy, R Mariadasse, M Ahmad… - PLoS Computational …, 2021 - journals.plos.org
Apart from the canonical fingers, palm and thumb domains, the RNA dependent RNA
polymerases (RdRp) from the viral order Nidovirales possess two additional domains. Of …

Transcriptomics and RNA-based therapeutics as potential approaches to manage SARS-CoV-2 infection

C Arriaga-Canon, L Contreras-Espinosa… - International Journal of …, 2022 - mdpi.com
SARS-CoV-2 is a coronavirus family member that appeared in China in December 2019 and
caused the disease called COVID-19, which was declared a pandemic in 2020 by the World …

MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?

F Abedi, R Rezaee, AW Hayes, S Nasiripour, G Karimi - Cell Cycle, 2021 - Taylor & Francis
To date, proposed therapies and antiviral drugs have been failed to cure coronavirus
disease 2019 (COVID-19) patients. However, at least two drug companies have applied for …

Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era

S Greco, A Madè, C Gaetano, Y Devaux… - Journal of Translational …, 2020 - Springer
Abstract COronaVIrus Disease 19 (COVID-19) is caused by the infection of the Severe Acute
Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Although the main clinical …

[HTML][HTML] The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review

LD Rizkita, I Astuti - Journal of Pharmaceutical Analysis, 2021 - Elsevier
Abstract Since the World Health Organization (WHO) declared COVID-19, the disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a pandemic …

Identification of neutrophil-related factor LCN2 for predicting severity of patients with influenza a virus and SARS-CoV-2 infection

Z Huang, H Li, S Liu, J Jia, Y Zheng, B Cao - Frontiers in Microbiology, 2022 - frontiersin.org
Background Influenza and COVID-19 are respiratory infectious diseases that are
characterized by high contagiousness and high mutation and pose a serious threat to global …

High‐throughput sequencing and exploration of the lncRNA‐circRNA‐miRNA‐mRNA network in type 2 diabetes mellitus

F Yang, Y Chen, Z Xue, Y Lv, L Shen… - BioMed Research …, 2020 - Wiley Online Library
Objective. Long noncoding RNA (lncRNA) and circular RNA (circRNA) are receiving
increasing attention in diabetes research. However, there are still many unknown lncRNAs …

mRNA-lncRNA Co-expression network analysis reveals the role of lncRNAs in immune dysfunction during severe SARS-CoV-2 infection

S Mukherjee, B Banerjee, D Karasik… - Viruses, 2021 - mdpi.com
The recently emerged SARS-CoV-2 virus is responsible for the ongoing COVID-19
pandemic that has rapidly developed into a global public health threat. Patients severely …